Skip to content

Yew Bio-Pharm Group, Inc.: 10-Q filed 2021-08-16

What Yew Bio-Pharm Group, Inc. reported in its quarterly report filed 2021-08-16 (fiscal Q2 2021): 43 published measures, 118 facts as tagged in accession 0001493152-21-020137.

This filing

Form
10-Q (quarterly report)
Filed
2021-08-16
Fiscal period
fiscal Q2 2021
Accession
0001493152-21-020137 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Yew Bio-Pharm Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-06-3063,254,104USD
At 2020-12-3158,446,662USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-06-3014,936,043USD
At 2020-12-3112,964,094USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-06-3048,327,058USD
At 2020-12-3145,482,568USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-06-30166,931USD
At 2020-12-31563,792USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-544,777USD91
2021-01-01 to 2021-06-302,373,361USD181
2020-04-01 to 2020-06-30737,567USD91
2020-01-01 to 2020-06-30888,979USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-06-301,036,171USD181
2020-01-01 to 2020-06-307,037,722USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-06-3058,372USD181
2020-01-01 to 2020-06-3039,349USD182

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-04-01 to 2021-06-3014,843,569USD91
2021-01-01 to 2021-06-3023,580,883USD181
2020-04-01 to 2020-06-309,562,157USD91
2020-01-01 to 2020-06-3011,591,339USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-06-30341,831USD181
2020-01-01 to 2020-06-3070,960USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-06-30-1,714,509USD181
2020-01-01 to 2020-06-30-6,069,808USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-06-3033,788,966USD
At 2020-12-3131,415,605USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-04-01 to 2021-06-3051,700,000shares91
2021-01-01 to 2021-06-3051,700,000shares181
2020-04-01 to 2020-06-3051,700,000shares91
2020-01-01 to 2020-06-3051,700,000shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-04-01 to 2021-06-3051,700,000shares91
2021-01-01 to 2021-06-3051,700,000shares181
2020-04-01 to 2020-06-3051,700,000shares91
2020-01-01 to 2020-06-3051,700,000shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-0.01USD/shares91
2021-01-01 to 2021-06-300.05USD/shares181
2020-04-01 to 2020-06-300.01USD/shares91
2020-01-01 to 2020-06-300.02USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-0.01USD/shares91
2021-01-01 to 2021-06-300.05USD/shares181
2020-04-01 to 2020-06-300.01USD/shares91
2020-01-01 to 2020-06-300.02USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-04-01 to 2021-06-301,859USD91
2021-01-01 to 2021-06-301,859USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-06-30528,052USD
At 2020-12-31516,921USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-430,641USD91
2021-01-01 to 2021-06-302,536,066USD181
2020-04-01 to 2020-06-30856,500USD91
2020-01-01 to 2020-06-301,013,888USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-06-3020,520,237USD
At 2020-12-319,989,384USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-06-3013,496,790USD
At 2020-12-3110,525,110USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-06-301,224,487USD
At 2020-12-31423,881USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-06-302,704,268USD
At 2020-12-31217,689USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-04-01 to 2021-06-30202,613USD91
2021-01-01 to 2021-06-30-1,807,121USD181
2020-04-01 to 2020-06-30428,883USD91
2020-01-01 to 2020-06-30713,750USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-06-30110,265USD
At 2020-12-3114,608USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-228,028USD91
2021-01-01 to 2021-06-30728,945USD181
2020-04-01 to 2020-06-301,285,383USD91
2020-01-01 to 2020-06-301,727,638USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-04-01 to 2021-06-3015,071,597USD91
2021-01-01 to 2021-06-3022,851,938USD181
2020-04-01 to 2020-06-308,276,774USD91
2020-01-01 to 2020-06-309,863,701USD182

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-04-01 to 2021-06-30208,285USD91
2021-01-01 to 2021-06-30482,058USD181
2020-04-01 to 2020-06-30235,417USD91
2020-01-01 to 2020-06-30516,944USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-06-3051,700,000shares
At 2020-12-3151,700,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-06-309,644,731USD
At 2020-12-319,644,731USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-06-301,079,373USD
At 2020-12-31608,244USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2021-06-3048,318,061USD
At 2020-12-3145,482,568USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-06-30306,418USD
At 2020-12-31333,402USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-06-30321,595USD
At 2020-12-31357,885USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-06-30143,351USD
At 2020-12-3190,989USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-545,738USD91
2021-01-01 to 2021-06-302,366,228USD181
2020-04-01 to 2020-06-30737,567USD91
2020-01-01 to 2020-06-30888,979USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-547,597USD91
2021-01-01 to 2021-06-302,364,369USD181
2020-04-01 to 2020-06-30737,567USD91
2020-01-01 to 2020-06-30888,979USD182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-04-01 to 2021-06-30178,058USD91
2021-01-01 to 2021-06-302,844,480USD181
2020-04-01 to 2020-06-30839,856USD91
2020-01-01 to 2020-06-30175,224USD182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-04-01 to 2021-06-30136,232USD91
2021-01-01 to 2021-06-30181,604USD181
2020-04-01 to 2020-06-30-73USD91
2020-01-01 to 2020-06-3013,417USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-04-01 to 2021-06-30-115,097USD91
2021-01-01 to 2021-06-30-169,838USD181
2020-04-01 to 2020-06-30-118,933USD91
2020-01-01 to 2020-06-30-124,909USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-06-30254,559USD181
2020-01-01 to 2020-06-30235,594USD182

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2021-01-01 to 2021-06-3051,195USD181
2020-01-01 to 2020-06-3052,674USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-06-302,483,797USD181
2020-01-01 to 2020-06-30-3,429,536USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-06-30-208,439USD181
2020-01-01 to 2020-06-30-827,706USD182

Inspect the source

Entity
Yew Bio-Pharm Group, Inc. / CIK 0001548240
Captured
SEC response SHA-256
42d239bf62595328b4b0f26c5a40397396731e01ab6dfcaf5b29c1b41870e6be

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001548240.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))